Roger G. Deeley reappointed Vice-Dean Research in the Faculty of Health Sciences and Vice President Health Sciences Research at Kingston General Hospital
Roger Deeley has been reappointed as Vice-Dean Research in the Faculty of Health Sciences at Queen’s University and Vice President Health Sciences Research at Kingston General Hospital and for the Kingston teaching hospitals for a second five-year term commencing January 1, 2012. These appointments are announced by Dr. Alan Harrison, Provost and Vice-Principal (Academic) at Queen’s University, and Ms. Leslee Thompson, President and Chief Executive Officer at Kingston General Hospital.
Following ten years with the National Cancer Institute at the National Institutes of Health in the United States, Dr. Deeley came to Queen’s University in 1980. He was promoted to the rank of Professor in 1984 and in 1987 he was appointed as the first holder of the Joseph S. Stauffer Chair and as Director of the Cancer Research Laboratories. He served as Director of the Division of Research for Cancer Care Ontario from 1988 to 2007 and since 2003 he has also been the Director of Queen’s Cancer Research Institute. Dr. Deeley has held the joint position of Vice-Dean Research in the Faculty of Health Sciences and Vice President Health Sciences Research at Kingston General Hospital since 2007. Dr. Deeley is a member of the Department of Pathology and Molecular Medicine with cross-appointments in the Department of Biomedical and Molecular Sciences and the Department of Oncology.
Dr. Deeley has maintained an active, internationally recognized research program that has been continuously funded from sources such as the Canadian Institutes of Health Research, the National Cancer Institute of Canada, the Heart and Stroke Foundation of Ontario, and industry. He has also been responsible for developing a number of major research initiatives, which together with his own research program, have garnered over $32M in funding. Dr. Deeley has extensive experience with research funding agencies and he has been involved in both provincial and national cancer control research agendas. Over the course of his career, Dr. Deeley has published numerous peer-reviewed research papers, reviews and book chapters, and he is also co-inventor on a number of patents related to the discovery of the multi-drug resistance protein, MRP1. Dr. Deeley was co-recipient in 2005 of the Robert L. Noble Prize presented jointly by the National Cancer Institute of Canada and the Canadian Cancer Society, and in 2007 he was the recipient of the National Cancer Institute of Canada’s Diamond Jubilee Award for outstanding contributions to cancer research.
